A detailed history of Asset Dedication, LLC transactions in Beam Therapeutics Inc. stock. As of the latest transaction made, Asset Dedication, LLC holds 268 shares of BEAM stock, worth $6,145. This represents 0.0% of its overall portfolio holdings.

Number of Shares
268
Previous 268 -0.0%
Holding current value
$6,145
Previous $6,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 16, 2024

BUY
$23.46 - $45.07 $4,692 - $9,014
200 Added 294.12%
268 $9,000
Q4 2023

Feb 08, 2024

SELL
$17.69 - $30.76 $3,538 - $6,152
-200 Reduced 74.63%
68 $2,000
Q1 2022

Apr 21, 2022

BUY
$53.73 - $82.16 $3,653 - $5,586
68 Added 34.0%
268 $15,000
Q3 2021

Oct 18, 2021

BUY
$84.37 - $133.6 $16,874 - $26,720
200 New
200 $17,000

Others Institutions Holding BEAM

About Beam Therapeutics Inc.


  • Ticker BEAM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 70,354,600
  • Market Cap $1.61B
  • Description
  • Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...
More about BEAM
Track This Portfolio

Track Asset Dedication, LLC Portfolio

Follow Asset Dedication, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Asset Dedication, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Asset Dedication, LLC with notifications on news.